Rote William E.'s Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed May 12, 2022
- Accession no.
- 0001209191-22-028710
- Filed
- May 12, 2022
- Trade date
- May 11, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $33.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rote William E.CIK 0001698262 | Officer (Senior Vice President, R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | Common Stock | SSaleDisposed | −750 | $21.93 | −$16,447.5 | 44,485 | Direct | |
| May 11, 2022 | Common Stock | SSaleDisposed | −813 | $21.52 | −$17,495.76 | 43,672 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.